Daro-PET: PSMA PET After Short-Course Darolutamide in Prostate CancerByJose Mauricio Mota, MD, PhDFebruary 27th 2026Phase 2 Daro-PET tests short-course darolutamide to boost PSMA PET signal in high-risk localized prostate cancer, guiding improved imaging interpretation.